A phase II study of multimodality treatment for locally advanced cervical cancer: Neoadjuvant carboplatin and paclitaxel followed by radical hysterectomy and adjuvant cisplatin chemoradiation

Annals of Oncology

Volumn 14, Issue 8, 2003, Pages 1278-1284

  Deunas Gonzalez A ^a,b   Lopez Graniel C ^a   Gonzalez Enciso A ^a   Cetina, L ^a   Rivera, L ^a   Mariscal, I ^a   Montalvo, G ^a   Gomez E ^a   de la Garza, J ^a   Chanona, G ^a   Mohar, A ^a,b  

^a INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Cervical carcinoma; Concomitant chemoradiation neoadjuvant chemotherapy; Radical hysterectomy

Indexed keywords

ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTIDIARRHEAL AGENT; ANTIEMETIC AGENT; CARBOPLATIN; CISPLATIN; COLONY STIMULATING FACTOR; GLUCOSE; PACLITAXEL; STEROID;

ADULT; ADVANCED CANCER; AGED; ANEMIA; AREA UNDER THE CURVE; ARTICLE; BLOOD TOXICITY; BRACHYTHERAPY; CANCER ADJUVANT THERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG FEVER; DRUG HYPERSENSITIVITY; DRUG INFUSION; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FOLLOW UP; GASTROINTESTINAL TOXICITY; GRANULOCYTOPENIA; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKOPENIA; MOUTH DISEASE; MULTIMODALITY CANCER THERAPY; NAUSEA; NEUROPATHY; NEUTROPENIA; PATHOLOGY; PELVIS LYMPH NODE; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION DOSE; RADICAL HYSTERECTOMY; SKIN TOXICITY; STATISTICAL ANALYSIS; SURGICAL TECHNIQUE; THROMBOCYTOPENIA; TIME; TREATMENT OUTCOME; UROGENITAL TRACT DISEASE; UTERINE CERVIX CANCER; VOMITING;

EID: 17744415907     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/mdg333     Document Type: Article

References (41)

1. Mohar A, Frias-Mendivil M. Epidemiology of cervical cancer. Cancer Invest 2000; 18: 584-590.
2. Landoni F, Maneo, A, Colombo A et al. Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet 1997; 350: 535-540.
3. Tierney JF, Stewart LA, Parmar MK. Can the published data tell us about the effectiveness of neoadjuvant chemotherapy for locally advanced cancer of the uterine cervix? Eur J Cancer 1999; 35: 406-409.
4. Peters WA III, Liu PY, Barrett R et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 2000; 18: 1606-1613.
5. Morris M, Eifel PJ, Lu J et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 1999; 340: 1137-1143.
6. Keys HM, Bundy BN, Stehman FB et al. A comparison of weekly cisplatin during radiation therapy versus irradiation alone each followed by adjuvant hysterectomy in bulky stage IB cervical carcinoma: a randomized trial of the Gynecology Oncology Group. N Engl J Med 1999; 340: 1154-1161.
7. Rose PG, Bundy BN, Watkins EB et al. Concurrent cisplatin-based chemoradiation improves progression-free survival in advanced cervical cancer: results of a randomized Gynecologic Oncology Group study. N Engl J Med 1999; 340: 1144-1153.
8. Whitney CW, Sause W, Bundy BN et al. A randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stages IIB-IVA carcinoma of the cervix with negative paraaortic lymph nodes. A Gynecologic Oncology Group and Southwest Oncology Group Study. J Clin Oncol 1999; 17: 1339-1348.
9. Wong LC, Ngan HYS, Cheung ANY et al. Chemoradiation and adjuvant chemotherapy in cervical cancer. J Clin Oncol 1999; 17: 2055-2060.
10. Roberts KB, Urdaneta N, Vera R et al. Interim results of a randomized trial of mitomycin C as an adjunct to radical radiotherapy in the treatment of locally advanced squamous-cell carcinoma of the cervix. Int J Cancer 2000; 90: 206-223.
11. Pearcey R, Brundage M, Drouin P et al. Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix. J Clin Oncol 2002; 20: 966-972.
12. Green JA, Kirwan JM, Tierney JF et al. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet 2001; 358: 781-786.
13. Sardi J, Sananes C, Giaroli A et al. Neoadjuvant chemotherapy in cervical carcinoma stage IIB: a randomized controlled trial. Int J Gynecol Cancer 1998; 8: 441-450.
14. Sardi J, Giaroli A, Sananes C et al. Randomized trial with neoadjuvant chemotherapy in stage IIIB squamous carcinoma of the cervix uteri: an unexpected therapeutic management. Int J Gynecol Cancer 1996; 6: 85-93.
15. Benedetti-Panici P, Greggi S, Colombo A et al. Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced squamous cell cervical cancer. Results from the Italian Multicenter Randomized Trial. J Clin Oncol 2002; 20: 179-188.
16. Duenas-Gonzalez A, Lopez-Graniel C, Gonzalez-Enciso A et al. Concomitant chemoradiation versus neoadjuvant chemotherapy in locally advanced cervical carcinoma. Results from two consecutive phase II trials. Ann Oncol 2002; 13: 1212-1219.
17. Minagawa Y, Kigawa J, Irie T et al. Radical surgery following neodjuvant chemotherapy for patients with stage IIIB cervical cancer. Ann Surg Oncol 1998; 5: 539-543.
18. Sugiyama T, Nishida T, Hasuo Y et al. Neoadjuvant intraarterial chemotherapy followed by radical hysterectomy and/or radiotherapy for locally advanced cervical cancer. Gynecol Oncol 1998; 69: 130-136.
19. Kigawa J, Minagawa Y, Ihshihara H et al. The role of neoadjuvant intraarterial infusion chemotherapy with cisplatin and bleomycin for locally advanced cervical cancer. Am J Clin Oncol 1996; 19: 255-259.
20. Sardi J, Sananes C, Giaroli A et al. Neoadjuvant chemotherapy in locally advanced carcinoma of the cervix uteri. Gynecol Oncol 1990; 38: 486-493.
21. Duenas-Gonzalez A, Mota A, Lopez-Graniel C et al. The advantages of concurrent chemoradiation after neoadjuvant chemotherapy for locally advanced cervical carcinoma. Arch Med Res 2002; 33: 201-202.
22. Eddy GL. Neoadjuvant chemotherapy before surgery in cervical cancer. NCI Monogr 1996; 21: 93-96.
23. Sedlis A, Bundy BN, Rotman MZ et al. A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a Gynecologic Oncology Group study. Gynecol Oncol 1999; 73: 177-183.
24. Duenas-Gonzalez A, Lopez-Graniel C, Gonzalez AE et al. Induction chemotherapy with gemcitabine and oxaliplatin for locally advanced cervical carcinoma. Am J Clin Oncol 2003; 26: 22-25.
25. Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
26. Trimble EL, Ungerleider RS, Abrams JA et al. Neoadjuvant therapy in cancer treatment. Cancer 1993; 72 (Suppl 11): 3515-3524.
27. Harris DT. Introduction: adjuvant and neoadjuvant therapy. Semin Oncol 1995; 22: 529.
28. Forastiere AA, Urba SG, Liggett W. Neoadjuvant therapy. Cancer J Sci Am 1996; 2: 126.
29. Monk BJ, Alberts DS, Burger RA et al. In vitro phase II comparison of the cytotoxicity of a novel platinum on fresh, human cervical cancers. Gynecol Oncol 1998; 71: 308-312.
30. Weiss GR, Green S, Hannigan EV et al. A phase II trial of carboplatin for recurrent or metastatic squamous carcinoma of the uterine cervix: a Southwest Oncology Group study. Gynecol Oncol 1990; 39: 332-336.
31. Gallo D, Ferlini C, Distefano M et al. Anti-tumour activity of a panel of taxanes toward a cellular model of human cervical cancer. Cancer Chemother Pharmacol 2000; 45: 127-132.
32. Kudelka AP, Winn R, Edwards CL et al. Activity of paclitaxel in advanced or recurrent squamous cell cancer of the cervix. Clin Cancer Res 1996; 2: 1285-1288.
33. Piver MS, Ghamande SA, Eltabbakh GH et al. First-line chemotherapy with paclitaxel and platinum for advanced and recurrent cancer of the cervix - a phase II study. Gynecol Oncol 1999; 75: 334-337.
34. Rose PG, Blessing JA, Gershenson DM et al. Paclitaxel and cisplatin as first-line therapy in recurrent or advanced squamous cell carcinoma of the cervix: a gynecologic oncology group study. J Clin Oncol 1999; 17: 2676-2680.
35. Papadimitriou CA, Sarris K, Moulopoulos LA et al. Phase II trial of paclitaxel and cisplatin in metastatic and recurrent carcinoma of the uterine cervix. J Clin Oncol 1999; 17: 761-766.
36. Dueñas-Gonzalez A, Gonzalez EA, Lopez-Graniel C et al. A phase II study of gemcitabine and cisplatin combination as induction chemotherapy for untreated locally advanced cervical carcinoma. Ann Oncol 2001; 12: 541-547.
37. Pignata S, Silvestro G, Ferrari E et al. Phase II study of cisplatin and vinorelbine as first-line chemotherapy in patients with carcinoma of the uterine cervix. J Clin Oncol 1999; 17: 756-760.
38. Sugiyama T, Nishida T, Kumagai S et al. Combination therapy with irinotecan and cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancer. Br J Cancer 1999; 81: 95-98.
39. Zanetta G, Lissoni A, Pellegrino A et al. Neoadjuvant chemotherapy with cisplatin, ifosfamide and paclitaxel for locally advanced squamous-cell cervical cancer. Ann Oncol 1998; 9: 977-980.
40. Lopez-Graniel C, Reyes M, Chanona G et al. Type III radical hysterectomy after induction chemotherapy for patients with locally advanced cervical carcinoma. Int J Gynecol Cancer 2001; 11: 210-217.
41. Berumen J, Ordonez RM, Lazcano E et al. Asian-American variants of human papillomavirus 16 and risk for cervical cancer: a case-control study. J Natl Cancer Inst 2001; 93: 1325-1330.